(a) Overgrowth of round cells with eosinophilic cytoplasm in a sheet-like growth pattern. Note the residual teratomatous (glandular) component in the right upper corner. (b) High-power view of the ...
Based on the NCCN 1.2026 guidelines for the management of CSI seminoma, surveillance is strongly preferred for pT1-pT3 tumors, and the NCCN does not recommend risk-adapted treatment for CSI seminoma ...
The 2026 GU ASCO annual meeting featured a testicular cancer session and a presentation by Dr. Jennifer King discussing a ...
Testicular cancer is one of the most common cancers affecting young men, especially those between the ages of 20 and 40.
Testicular germ cell tumors are on the rise in the US. The incidence among Hispanic men now surpasses that of non-Hispanic White men, who have historically had the highest incidence. The incidence of ...
Fibroblast-activating protein (FAP) expression and first clinical utility of 68Ga-FAPI-PET-CT in testicular cancer patients. Real world data: Survival outcomes of patients with poor prognosis ...
Phase I trial of chidamide, an oral HDAC inhibitor, in combination with oral etoposide in patients with refractory/recurrent neuroblastoma. Type II RAF inhibitor tovorafenib in relapsed/refractory ...
Women with a type of ovarian cancer known as germ cell tumors have a worse prognosis than men with similar tumors, i.e. testicular cancer. After five years with the disease, 98 percent of men were ...
A new study co-led by WEHI has found a simple blood test can help identify the early-stage testicular cancer patients who are ...
Two of the researchers were also the first to create ovarian organoids from mouse embryonic stem cells, in 2021.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results